SCHEMBL4245196

SCHEMBL4245196

C=CCC(=O)O.CCN(CC)CC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.41
EYA2 O00167 1/20 0.41
APP P05067 1/20 0.41
ACE P12821 1/20 0.41
ALOX15 P16050 3/20 0.39
TSHR P16473 3/20 0.39
KDM4E B2RXH2 2/20 0.39
BLM P54132 2/20 0.39
PMP22 Q01453 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 1/20 0.39
CHRM2 P08172 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butadiene SCHEMBL1628441 0.85 TDP1 (0.46) TDP1EYA2APPACEALOX15
SCHEMBL14890359 0.82 TDP1 (0.58) TDP1EYA2APPACEALOX15
SCHEMBL120640 0.82
SCHEMBL5922611 0.81 TDP1 (0.42) TDP1EYA2APPACEALOX15
SCHEMBL26558171 0.81 TDP1 (0.42) TDP1EYA2APPACEALOX15
SCHEMBL77671 0.79 TDP1 (0.55) TDP1EYA2APPACEALOX15
SCHEMBL9304702 0.79 TDP1 (0.55) TDP1EYA2APPACEALOX15
SCHEMBL9306714 0.79 TDP1 (0.55) TDP1EYA2APPACEALOX15
SCHEMBL9306621 0.79 TDP1 (0.55) TDP1EYA2APPACEALOX15
Potassium SCHEMBL3894343 0.79 TDP1 (0.55) TDP1EYA2APPACEALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200146978-A1 TASTE-MASKED PHARMACEUTICAL COMPOSITIONS TEAL MIDCO HOLDINGS, L.P. 2020-05-14 US claimed
US-10568832-B2 Taste-masked pharmaceutical compositions ADARE PHARMACEUTICALS, INC. (US) 2020-02-25 US claimed
US-9884014-B2 Taste-masked pharmaceutical compositions ADARE PHARMACEUTICALS, INC. (US) 2018-02-06 US claimed
US-8962022-B2 Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family APTALIS PHARMATECH, INC. (US) 2015-02-24 US claimed
WO-2009102830-A1 ORALLY DISINTEGRATING TABLET COMPOSITIONS OF RANITIDINE AND METHODS OF MANUFACTURE EURAND INC (US) 2009-08-20 WO claimed
US-20090202630-A1 ORALLY DISINTEGRATING TABLET COMPOSITIONS OF RANITIDINE AND METHODS OF MANUFACTURE VENKATESH GOPI 2009-08-13 US claimed
WO-2008119033-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ACTIVE SUBSTANCE FROM THE SUBSTITUTED BENZHYDRYLPIPERAZINE FAMILY EURAND, INC. (US) 2008-10-02 WO claimed
US-20080241237-A1 Taste-masked microparticles of hydroxyzine, cetirizine (hydrochloride), efletirizine, meclizine, buclizine or levocetirizine dihydrochloride coated with a taste-masking coating of a water insoluble polymer and an enteric polymer; orally disintegrating tablets; storage stability ADARE PHARMACEUTICALS, INC. 2008-10-02 US claimed
US-20060078614-A1 Taste-masked pharmaceutical compositions TEAL MIDCO HOLDINGS, L.P. 2006-04-13 US claimed
US-4490407-A SPRAYING, DRYING, TO FORM COATED GRANULES LABORATOIRE L. LAFON (FR) 1984-12-25 US claimed
EP-3750540-B1 CHOROIDAL NEOVASCULARIZATION SUPPRESSOR OR DRUSEN FORMATION SUPPRESSOR LINK GENOMICS INC (JP) 2023-12-13 EP disclosed
EP-3750540-A1 CHOROIDAL NEOVASCULARIZATION SUPPRESSOR OR DRUSEN FORMATION SUPPRESSOR Link Genomics, Inc. (JP) 2020-12-16 EP disclosed
US-10761087-B2 Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same LINK GENOMICS, INC. (JP) 2020-09-01 US disclosed
EP-3391883-B1 CHOROIDAL NEOVASCULARIZATION SUPPRESSOR OR DRUSEN FORMATION SUPPRESSOR, AND METHOD FOR ASSESSING OR SCREENING FOR SAME LINK GENOMICS INC (JP) 2020-08-19 EP disclosed
US-20180364216-A1 CHOROIDAL NEOVASCULARIZATION SUPPRESSOR OR DRUSEN FORMATION SUPPRESSOR, AND METHOD FOR ASSESSING OR SCREENING FOR SAME ROHTO PHARMACEUTICAL CO., LTD. (JP) 2018-12-20 US disclosed
US-20080124415-A1 Fat Combustion Accelerator SUNTORY HOLDINGS LIMITED (JP) 2008-05-29 US disclosed
US-20070099853-A1 Agent for improving physiological motor functions SUNTORY LIMITED (JP) 2007-05-03 US disclosed
EP-1767203-A1 FAT COMBUSTION ACCELERATOR SUNTORY LIMITED (JP) 2007-03-28 EP disclosed
EP-1639902-A1 MOVEMENT PHYSIOLOGY IMPROVER SUNTORY LIMITED (JP) 2006-03-29 EP disclosed
US-4490407-A SPRAYING, DRYING, TO FORM COATED GRANULES LABORATOIRE L. LAFON (FR) 1984-12-25 US disclosed